Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity
Date
2018-09-26
Authors
Ivanova, Kateryna
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Recent studies have revealed that fibroblast growth
factor 21 (FGF21) plays important role in energy metabolism
regulation. FGF21 contributes to many age-related
metabolic disorders, e.g. atherosclerosis, obesity, type 2
diabetes, and some cardiovascular diseases
Description
Keywords
fibroblast growth factor 21, dyslipidemia, coronary artery disease
Citation
Ivanova K. V. Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity / K. V. Ivanova // Український кардіологічний журнал. – 2018. – Додаток 1 : ХІХ Національний конгрес кардіологів України: тези доповідей, Київ, 26–28 вересня 2018. – С. 56.